Online inquiry

IVTScrip™ mRNA-Human ARL6IP1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK27447MR)

This product GTTS-WK27447MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the ARL6IP1 protein. This product can be used in Gonadal mitotic phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001313858.1
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 23204
UniProt ID Q15041
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARL6IP1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK27447MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK26891MR IVTScrip™ mRNA-Human ASAP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASAP1
GTTS-WK27165MR IVTScrip™ mRNA-Human ARPC1A, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ARPC1A
GTTS-WK2112MR IVTScrip™ mRNA-Human CYR61, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA CYR61
GTTS-WK25945MR IVTScrip™ mRNA-Human ARL5B, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARL5B
GTTS-WK24083MR IVTScrip™ mRNA-Human ARHGAP15, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARHGAP15
GTTS-WK20641MR IVTScrip™ mRNA-Human ANKUB1, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKUB1
GTTS-WK23225MR IVTScrip™ mRNA-Human ARID4A, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARID4A
GTTS-WK22925MR IVTScrip™ mRNA-Human ARID4A, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARID4A
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →